Pall Biotech offers a blend of innovative traditional, single-use and continuous processing technologies and services to create scalable bioprocessing solutions. From concept through to design, validation and production, Pall leverages best-in class technologies for all bioprocessing applications. Pall (Schweiz) GmbH has been acquired by Cytiva in 2023.